These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 277117)

  • 41. Kinetics of N- and C-hydroxylations of 2-acetylaminofluorene in male Sprague-Dawley rat liver microsomes: implications for carcinogenesis.
    McManus ME; Minchin RF; Sanderson N; Wirth PJ; Thorgeirsson SS
    Cancer Res; 1983 Aug; 43(8):3720-4. PubMed ID: 6861141
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Microsomal N-hydroxylase modification as a first step in carcinogenesis by arylamines [proceedings].
    Roberfroid M; Razzouk C; Mercier M
    Arch Int Physiol Biochim; 1977 Apr; 85(2):429-31. PubMed ID: 71125
    [No Abstract]   [Full Text] [Related]  

  • 43. Metabolism of N-hydroxy-2-acetylaminofluorene and N-hydroxy-2-aminofluorene by guinea pig liver microsomes.
    Razzouk C; Batardy-Grégoire M; Roberfroid M
    Cancer Res; 1982 Nov; 42(11):4712-8. PubMed ID: 7127306
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Induction and modification of rat liver microsomal arylamide N-hydroxylase by various pretreatments.
    Razzouk C; Batardy-Grégoire M; Roberfroid M
    Mol Pharmacol; 1982 Mar; 21(2):449-57. PubMed ID: 7099145
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Metabolic activation of aromatic amines and azo dyes.
    Bartsch H
    IARC Sci Publ; 1981; (40):13-30. PubMed ID: 6799396
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Specific modification of the properties of the N-hydroxylase. Relationship with carcinogenesis by aromatic amides.
    Razzouk C; Roberfroid M; Mercier M
    Arch Toxicol Suppl; 1978; (1):291-4. PubMed ID: 277117
    [TBL] [Abstract][Full Text] [Related]  

  • 47.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 48.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 49.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 50.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 51.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 52.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 3.